Home/Case studies
Case studies

Sponsor case studies

What sponsors get from ImmunoMark: the real results from London 2026, and profiles of how different types of company use the 1:1 meetings, talks and stand to build pipeline with oncology R&D teams.

Real resultsAll London 2026 sponsorsLondon 2026 Sponsor ResultsReal figures from the London 2026 post-show report: who attended, the meetings sponsors held and what they said.200+meetings conducted15–25meetings per sponsor300+attendees from 100+ companies70%senior decision-makersRead the case study →Sponsor profileSpecialty biomarker CROSpecialty Biomarker CRO Builds a Translational PipelineTen pre-booked 1:1s, a Day 1 talk and an email to registered attendees turned into an estimated £990k of study pipeline.10pre-booked 1:1 meetings22qualified conversations5–6qualified opportunitiesRead the case study →Sponsor profileSpatial biology companySpatial Biology Company Reaches Pharma Pathology TeamsA Gold package put a spatial platform in front of pathology and biomarker discovery leads, for an estimated £510k of pipeline.6pre-booked 1:1 meetings17qualified conversations4–5qualified opportunitiesRead the case study →Sponsor profilePreclinical models CROPreclinical CRO Builds Pipeline From a Meetings-Only PackageSeven pre-arranged meetings and no stand: a lean first year in oncology with an estimated £300k of pipeline.7pre-booked 1:1 meetings16qualified conversations4qualified opportunitiesRead the case study →Sponsor profileCell analysis and proteomics platformProteomics Platform Turns a Talk and Stand Into LeadsA 15-minute talk and a stand, with no pre-booked meetings, still produced 18 qualified conversations and an estimated £270k of pipeline.18qualified conversations4–5qualified opportunities£270kpipeline at 90 daysRead the case study →

Plan your 2027 sponsorship

San Diego (10–11 February 2027), London (3–4 March 2027) and Boston (June 2027). Tell us who you want to meet and we will send the prospectus and current availability.